Ron A. Wevers

29.4k total citations · 1 hit paper
490 papers, 17.3k citations indexed

About

Ron A. Wevers is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, Ron A. Wevers has authored 490 papers receiving a total of 17.3k indexed citations (citations by other indexed papers that have themselves been cited), including 281 papers in Molecular Biology, 137 papers in Clinical Biochemistry and 112 papers in Physiology. Recurrent topics in Ron A. Wevers's work include Metabolism and Genetic Disorders (137 papers), Lysosomal Storage Disorders Research (61 papers) and Glycosylation and Glycoproteins Research (59 papers). Ron A. Wevers is often cited by papers focused on Metabolism and Genetic Disorders (137 papers), Lysosomal Storage Disorders Research (61 papers) and Glycosylation and Glycoproteins Research (59 papers). Ron A. Wevers collaborates with scholars based in Netherlands, United States and Germany. Ron A. Wevers's co-authors include Udo F. H. Engelke, Baziel G.M. van Engelen, Éva Morava, Mireille C. P. Van Beekvelt, Willy N. J. M. Colier, Jan Smeıtınk, Dirk J. Lefeber, Ben J. H. M. Poorthuis, F.J.M. Gabreëls and J.G.N. de Jong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of the American Chemical Society.

In The Last Decade

Ron A. Wevers

480 papers receiving 16.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The frequency of lysosomal storage diseases in The Netherlands

1999 522 citations Ron A. Wevers et al. profile →

Peers

Countries citing papers authored by Ron A. Wevers

Since Specialization

Citations

This map shows the geographic impact of Ron A. Wevers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron A. Wevers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron A. Wevers more than expected).

Fields of papers citing papers by Ron A. Wevers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron A. Wevers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron A. Wevers. The network helps show where Ron A. Wevers may publish in the future.

Co-authorship network of co-authors of Ron A. Wevers

This figure shows the co-authorship network connecting the top 25 collaborators of Ron A. Wevers. A scholar is included among the top collaborators of Ron A. Wevers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron A. Wevers. Ron A. Wevers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Semi-Targeted Nuclear Magnetic Resonance Metabolomics via Parahydrogen-Induced Hyperpolarization for Enhanced Sensitivity to Metabolic Composition 2025 ·Journal of the American Chemical Society ·(unknown), Udo F. H. Engelke, Ruud L. E. G. Aspers, Jona Merx, Thomas J. Boltje, Jonathan Martens, Ron A. Wevers, Martin C. Feiters, Floris P. J. T. Rutjes, Marco Tessari	0
2	New treatment for pyridoxine-dependent epilepsy due to ALDH7A1 deficiency: first proof-of-principle of upstream enzyme inhibition in the mouse 2025 ·Brain Communications ·Clara D.M. van Karnebeek, Valérie Gailus‐Durner, Udo F. H. Engelke, Claudia Seisenberger, Susan Marschall, Nathalia Romanelli Vicente Dragano, Patricia da Silva‐Buttkus, Stefanie Leuchtenberger, Helmut Fuchs, Martin Hrabě de Angelis, Ron A. Wevers, Curtis R. Coughlin, Dirk J. Lefeber	1
3	A rare homozygous INS variant causes adult-onset diabetes 2024 ·BMJ Open Diabetes Research & Care ·(unknown), Tine Glendorf, Antonius E. van Herwaarden, Hanka Venselaar, (unknown), Ron A. Wevers, Jolein Gloerich, Alain J. van Gool, Cees J. Tack	0
4	Discovery of novel diagnostic biomarkers for Sjögren-Larsson syndrome by untargeted lipidomics 2024 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Frédéric M. Vaz, (unknown), Jan B. van Klinken, Henk van Lenthe, Martin A. T. Vervaart, Ronald J. A. Wanders, Mia L. Pras‐Raves, Michel van Weeghel, Gajja S. Salomons, Sacha Ferdinandusse, Ron A. Wevers, Michèl A.A.P. Willemsen	3
5	A spectroscopic test suggests that fragment ion structure annotations in MS/MS libraries are frequently incorrect 2024 ·Communications Chemistry ·(unknown), (unknown), (unknown), Kas J. Houthuijs, Rianne E. van Outersterp, Jonathan Martens, Ron A. Wevers, David S. Wishart, Giel Berden, Jos Oomens	17
6	Exome sequencing links the SUMO protease SENP7 with fatal arthrogryposis multiplex congenita, early respiratory failure and neutropenia 2023 ·Journal of Medical Genetics ·(unknown), (unknown), (unknown), (unknown), (unknown), Tamar Paperna, Mario García‐Domínguez, (unknown), (unknown), Eric S. Shinwell, (unknown), Doua Bakry, Adel Shalata, (unknown), Dvora Kidron, (unknown), Ron A. Wevers, Hanna Mandel, Alfred C.O. Vertegaal, Karin Weiss	6
7	PPA1 Deficiency Causes a Deranged Galactose Metabolism Recognizable in Neonatal Screening 2023 ·Metabolites ·(unknown), Judith Jans, (unknown), (unknown), Vassiliki Konstantopoulou, René G. Feichtinger, (unknown), Doris Mayr, Ron A. Wevers, Christian Thiel, Saskia B. Wortmann, Johannes A. Mayr	1
8	Distinguishing Oligosaccharide Isomers Using Far-Infrared Ion Spectroscopy: Identification of Biomarkers for Inborn Errors of Metabolism 2023 ·Analytical Chemistry ·Rianne E. van Outersterp, (unknown), Jona Merx, Udo F. H. Engelke, Nematollah Omidikia, (unknown), Kas J. Houthuijs, Giel Berden, (unknown), Dirk J. Lefeber, Michèl A.A.P. Willemsen, Jasmin Mecinović, Jeroen J. Jansen, Karlien L. M. Coene, Ron A. Wevers, Thomas J. Boltje, Jos Oomens, Jonathan Martens	3
9	Succinic semialdehyde dehydrogenase deficiency in mice and in humans: An untargeted metabolomics perspective 2023 ·Journal of Inherited Metabolic Disease ·(unknown), Udo F. H. Engelke, (unknown), (unknown), Jean‐Baptiste Roullet, Sanne Broekman, Erik de Vrieze, Erwin van Wijk, Mirjam M. C. Wamelink, Rafael Artuch, Ivo Barić, Jona Merx, Thomas J. Boltje, (unknown), Michèl A.A.P. Willemsen, Marcel M. Verbeek, Ron A. Wevers, K. Michael Gibson, Karlien L. M. Coene	3
10	Metabolite Identification Using Infrared Ion Spectroscopy─Novel Biomarkers for Pyridoxine-Dependent Epilepsy 2021 ·Analytical Chemistry ·Rianne E. van Outersterp, Udo F. H. Engelke, Jona Merx, Giel Berden, Mathias Paul, (unknown), Albrecht Berkessel, Marleen C.D.G. Huigen, Leo A. J. Kluijtmans, Jasmin Mecinović, Floris P. J. T. Rutjes, Clara D.M. van Karnebeek, Ron A. Wevers, Thomas J. Boltje, Karlien L. M. Coene, Jonathan Martens, Jos Oomens	23
11	Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase 2021 ·npj Parkinson s Disease ·Anouke van Rumund, Lukas Pavelka, Rianne A.J. Esselink, (unknown), Ron A. Wevers, Brit Mollenhauer, Rejko Krüger, Bastiaan R. Bloem, Marcel M. Verbeek	16
12	Amadori rearrangement products as potential biomarkers for inborn errors of amino-acid metabolism 2021 ·Communications Biology ·Rianne E. van Outersterp, Sam J. Moons, Udo F. H. Engelke, Herman Bentlage, (unknown), Arno van Rooij, Marleen C.D.G. Huigen, (unknown), E. van der Heeft, Leo A. J. Kluijtmans, Clara D.M. van Karnebeek, Ron A. Wevers, Giel Berden, Jos Oomens, Thomas J. Boltje, Karlien L. M. Coene, Jonathan Martens	23
13	Variable Selection in Untargeted Metabolomics and the Danger of Sparsity 2020 ·Metabolites ·Gerjen H. Tinnevelt, Udo F. H. Engelke, Ron A. Wevers, (unknown), Michèl A.A.P. Willemsen, Karlien L. M. Coene, Purva Kulkarni, Jeroen J. Jansen	5
14	SLC13A3 variants cause acute reversible leukoencephalopathy and α‐ketoglutarate accumulation 2019 ·Annals of Neurology ·Joseph P. Dewulf, Elsa Wiame, Imen Dorboz, Monique Elmaleh, Apolline Imbard, Dana Dumitriu, Malgorzata Rak, Agnès Bourillon, Raphaël Helaers, (unknown), Florence Renaldo, Odile Boespflug‐Tanguy, Marie‐Françoise Vincent, Jean‐François Benoist, Ron A. Wevers, Avner Schlessinger, Emile Van Schaftingen, Marie‐Cécile Nassogne, Manuel Schiff	19
15	Molecular identification in metabolomics using infrared ion spectroscopy 2017 ·Scientific Reports ·Jonathan Martens, Giel Berden, Rianne E. van Outersterp, Leo A. J. Kluijtmans, Udo F. H. Engelke, Clara D.M. van Karnebeek, Ron A. Wevers, Jos Oomens	59
16	Genotype-Specific Abnormalities in Mitochondrial Function Associate with Distinct Profiles of Energy Metabolism and Catecholamine Content in Pheochromocytoma and Paraganglioma 2013 ·Clinical Cancer Research ·Jyotsna U. Rao, Udo F. H. Engelke, Richard J. Rodenburg, Ron A. Wevers, Karel Pacák, Graeme Eisenhofer, Nan Qin, Benno Küsters, (unknown), Jacques W.M. Lenders, Ad R. Hermus, Arjen R. Mensenkamp, Henricus P. M. Kunst, Fred C.G.J. Sweep, Henri Timmers	44
17	SRD5A3 is required for the conversion of polyprenol to dolichol, essential for N-linked protein glycosylation 2010 ·(unknown), (unknown), Jennifer L. Silhavy, Stephanie Bielas, Bobby G. Ng, Ziqiang Guan, R. Scott Houliston, Dominika Swistun, Bassam R. Ali, (unknown), (unknown), C R Raetz, Ron A. Wevers, Ludwig Lehle, Hudson H. Freeze, Éva Morava, Lihadh Al‐Gazali, Joseph G. Gleeson	1
18	Maternal myo-inositol, glucose, and zinc status is associated with the risk of offspring with spina bifida 2003 ·American Journal of Obstetrics and Gynecology ·Pascal M.W. Groenen, Petronella G.M. Peer, Ron A. Wevers, Dorine W. Swinkels, Barbara Franke, Edwin C.M. Mariman, Régine P.M. Steegers‐Theunissen	81
19	β‐Ureidopropionase deficiency: A novel inborn error of metabolism discovered using NMR spectroscopy on urine 2001 ·Magnetic Resonance in Medicine ·Sytske H. Moolenaar, (unknown), Udo F. H. Engelke, Manfred Spraul, Eberhard Humpfer, Péter Dvortsák, Thomas Voït, Georg F. Hoffmann, Christa Bräutigam, André B. P. Kuilenburg, (unknown), P. Vreken, Ron A. Wevers	43
20	A review of biochemical and molecular genetic aspects of tyrosine hydroxylase deficiency including a novel mutation (291delC) 1999 ·Journal of Inherited Metabolic Disease ·Ron A. Wevers, J.F. de Rijk-van Andel, Chad A. Brautigam, (unknown), Lambert P.W.J. van den Heuvel, Gerry C. H. Steenbergen‐Spanjers, Jan Smeıtınk, G. F. Hoffmann, F.J.M. Gabreëls	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact